Medical Devices & Consumables

Global Poultry Viral Disease Vaccines Market Research Report 2026

This report delivers a comprehensive overview of the global Poultry Viral Disease Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Poultry Viral Disease Vaccines. The Poultry Viral Disease Vaccines market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Poultry Viral Disease Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Poultry Viral Disease Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Segment by Type
Live
Attenuated
Killed
by Application
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Poultry Viral Disease Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Poultry Viral Disease Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Poultry Viral Disease Vaccines Market Overview
1.1 Product Definition
1.2 Poultry Viral Disease Vaccines by Type
1.2.1 Global Poultry Viral Disease Vaccines Market Value by Type: 2025 vs 2032
1.2.2 Live
1.2.3 Attenuated
1.2.4 Killed
1.3 Poultry Viral Disease Vaccines by Application
1.3.1 Global Poultry Viral Disease Vaccines Market Value by Application: 2025 vs 2032
1.3.2 NDV
1.3.3 Marek ' s Disease
1.3.4 IBD
1.3.5 Infectious Bronchitis
1.3.6 Influenza
1.3.7 Others
1.4 Global Poultry Viral Disease Vaccines Market Size Estimates and Forecasts
1.4.1 Global Poultry Viral Disease Vaccines Revenue 2021–2032
1.4.2 Global Poultry Viral Disease Vaccines Sales 2021–2032
1.4.3 Global Poultry Viral Disease Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Poultry Viral Disease Vaccines Market Competition by Manufacturers
2.1 Global Poultry Viral Disease Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Poultry Viral Disease Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Poultry Viral Disease Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Poultry Viral Disease Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Poultry Viral Disease Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Poultry Viral Disease Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Poultry Viral Disease Vaccines, Date of Entry into the Industry
2.8 Global Poultry Viral Disease Vaccines Market Competitive Situation and Trends
2.8.1 Global Poultry Viral Disease Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Poultry Viral Disease Vaccines Players Market Share by Revenue
2.8.3 Global Poultry Viral Disease Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Poultry Viral Disease Vaccines Market Scenario by Region
3.1 Global Poultry Viral Disease Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Poultry Viral Disease Vaccines Sales by Region: 2021–2032
3.2.1 Global Poultry Viral Disease Vaccines Sales by Region: 2021–2026
3.2.2 Global Poultry Viral Disease Vaccines Sales by Region: 2027–2032
3.3 Global Poultry Viral Disease Vaccines Revenue by Region: 2021–2032
3.3.1 Global Poultry Viral Disease Vaccines Revenue by Region: 2021–2026
3.3.2 Global Poultry Viral Disease Vaccines Revenue by Region: 2027–2032
3.4 North America Poultry Viral Disease Vaccines Market Facts & Figures by Country
3.4.1 North America Poultry Viral Disease Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Poultry Viral Disease Vaccines Sales by Country (2021–2032)
3.4.3 North America Poultry Viral Disease Vaccines Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Poultry Viral Disease Vaccines Market Facts & Figures by Country
3.5.1 Europe Poultry Viral Disease Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Poultry Viral Disease Vaccines Sales by Country (2021–2032)
3.5.3 Europe Poultry Viral Disease Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poultry Viral Disease Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Poultry Viral Disease Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Poultry Viral Disease Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Poultry Viral Disease Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Poultry Viral Disease Vaccines Market Facts & Figures by Country
3.7.1 Latin America Poultry Viral Disease Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Poultry Viral Disease Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Poultry Viral Disease Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Poultry Viral Disease Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Poultry Viral Disease Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Poultry Viral Disease Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Poultry Viral Disease Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poultry Viral Disease Vaccines Sales by Type (2021–2032)
4.1.1 Global Poultry Viral Disease Vaccines Sales by Type (2021–2026)
4.1.2 Global Poultry Viral Disease Vaccines Sales by Type (2027–2032)
4.1.3 Global Poultry Viral Disease Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Poultry Viral Disease Vaccines Revenue by Type (2021–2032)
4.2.1 Global Poultry Viral Disease Vaccines Revenue by Type (2021–2026)
4.2.2 Global Poultry Viral Disease Vaccines Revenue by Type (2027–2032)
4.2.3 Global Poultry Viral Disease Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Poultry Viral Disease Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Poultry Viral Disease Vaccines Sales by Application (2021–2032)
5.1.1 Global Poultry Viral Disease Vaccines Sales by Application (2021–2026)
5.1.2 Global Poultry Viral Disease Vaccines Sales by Application (2027–2032)
5.1.3 Global Poultry Viral Disease Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Poultry Viral Disease Vaccines Revenue by Application (2021–2032)
5.2.1 Global Poultry Viral Disease Vaccines Revenue by Application (2021–2026)
5.2.2 Global Poultry Viral Disease Vaccines Revenue by Application (2027–2032)
5.2.3 Global Poultry Viral Disease Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Poultry Viral Disease Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Poultry Viral Disease Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boehringer Ingelheim Poultry Viral Disease Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Ceva
6.3.1 Ceva Company Information
6.3.2 Ceva Description and Business Overview
6.3.3 Ceva Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ceva Poultry Viral Disease Vaccines Product Portfolio
6.3.5 Ceva Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Company Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Zoetis Poultry Viral Disease Vaccines Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Vaxxinova®
6.5.1 Vaxxinova® Company Information
6.5.2 Vaxxinova® Description and Business Overview
6.5.3 Vaxxinova® Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Vaxxinova® Poultry Viral Disease Vaccines Product Portfolio
6.5.5 Vaxxinova® Recent Developments/Updates
6.6 Elanco
6.6.1 Elanco Company Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Elanco Poultry Viral Disease Vaccines Product Portfolio
6.6.5 Elanco Recent Developments/Updates
6.7 QYH Biotech Co., Ltd
6.7.1 QYH Biotech Co., Ltd Company Information
6.7.2 QYH Biotech Co., Ltd Description and Business Overview
6.7.3 QYH Biotech Co., Ltd Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 QYH Biotech Co., Ltd Poultry Viral Disease Vaccines Product Portfolio
6.7.5 QYH Biotech Co., Ltd Recent Developments/Updates
6.8 Pulike
6.8.1 Pulike Company Information
6.8.2 Pulike Description and Business Overview
6.8.3 Pulike Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Pulike Poultry Viral Disease Vaccines Product Portfolio
6.8.5 Pulike Recent Developments/Updates
6.9 Phibro Animal Health Corporation
6.9.1 Phibro Animal Health Corporation Company Information
6.9.2 Phibro Animal Health Corporation Description and Business Overview
6.9.3 Phibro Animal Health Corporation Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Phibro Animal Health Corporation Poultry Viral Disease Vaccines Product Portfolio
6.9.5 Phibro Animal Health Corporation Recent Developments/Updates
6.10 JinYu Biotechnology
6.10.1 JinYu Biotechnology Company Information
6.10.2 JinYu Biotechnology Description and Business Overview
6.10.3 JinYu Biotechnology Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 JinYu Biotechnology Poultry Viral Disease Vaccines Product Portfolio
6.10.5 JinYu Biotechnology Recent Developments/Updates
6.11 Harbin Pharmaceutical Group
6.11.1 Harbin Pharmaceutical Group Company Information
6.11.2 Harbin Pharmaceutical Group Description and Business Overview
6.11.3 Harbin Pharmaceutical Group Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Harbin Pharmaceutical Group Poultry Viral Disease Vaccines Product Portfolio
6.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.12 MEVAC
6.12.1 MEVAC Company Information
6.12.2 MEVAC Description and Business Overview
6.12.3 MEVAC Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 MEVAC Poultry Viral Disease Vaccines Product Portfolio
6.12.5 MEVAC Recent Developments/Updates
6.13 Venky's
6.13.1 Venky's Company Information
6.13.2 Venky's Description and Business Overview
6.13.3 Venky's Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Venky's Poultry Viral Disease Vaccines Product Portfolio
6.13.5 Venky's Recent Developments/Updates
6.14 Japfa Comfeed Indonesia
6.14.1 Japfa Comfeed Indonesia Company Information
6.14.2 Japfa Comfeed Indonesia Description and Business Overview
6.14.3 Japfa Comfeed Indonesia Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Japfa Comfeed Indonesia Poultry Viral Disease Vaccines Product Portfolio
6.14.5 Japfa Comfeed Indonesia Recent Developments/Updates
6.15 Nisseiken
6.15.1 Nisseiken Company Information
6.15.2 Nisseiken Description and Business Overview
6.15.3 Nisseiken Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Nisseiken Poultry Viral Disease Vaccines Product Portfolio
6.15.5 Nisseiken Recent Developments/Updates
6.16 Hile
6.16.1 Hile Company Information
6.16.2 Hile Description and Business Overview
6.16.3 Hile Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Hile Poultry Viral Disease Vaccines Product Portfolio
6.16.5 Hile Recent Developments/Updates
6.17 Hester Biosciences
6.17.1 Hester Biosciences Company Information
6.17.2 Hester Biosciences Description and Business Overview
6.17.3 Hester Biosciences Poultry Viral Disease Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Hester Biosciences Poultry Viral Disease Vaccines Product Portfolio
6.17.5 Hester Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poultry Viral Disease Vaccines Industry Chain Analysis
7.2 Poultry Viral Disease Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poultry Viral Disease Vaccines Production Mode & Process Analysis
7.4 Poultry Viral Disease Vaccines Sales and Marketing
7.4.1 Poultry Viral Disease Vaccines Sales Channels
7.4.2 Poultry Viral Disease Vaccines Distributors
7.5 Poultry Viral Disease Vaccines Customer Analysis
8 Poultry Viral Disease Vaccines Market Dynamics
8.1 Poultry Viral Disease Vaccines Industry Trends
8.2 Poultry Viral Disease Vaccines Market Drivers
8.3 Poultry Viral Disease Vaccines Market Challenges
8.4 Poultry Viral Disease Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Poultry Viral Disease Vaccines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Poultry Viral Disease Vaccines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Poultry Viral Disease Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Poultry Viral Disease Vaccines Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Poultry Viral Disease Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Poultry Viral Disease Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Poultry Viral Disease Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Poultry Viral Disease Vaccines Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Poultry Viral Disease Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Poultry Viral Disease Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Poultry Viral Disease Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Poultry Viral Disease Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Poultry Viral Disease Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Poultry Viral Disease Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Poultry Viral Disease Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Poultry Viral Disease Vaccines Sales by Region (K Units), 2021–2026
Table 18. Global Poultry Viral Disease Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Poultry Viral Disease Vaccines Sales by Region (K Units), 2027–2032
Table 20. Global Poultry Viral Disease Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Poultry Viral Disease Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Poultry Viral Disease Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Poultry Viral Disease Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Poultry Viral Disease Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Poultry Viral Disease Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Poultry Viral Disease Vaccines Sales by Country (K Units), 2021–2026
Table 27. North America Poultry Viral Disease Vaccines Sales by Country (K Units), 2027–2032
Table 28. North America Poultry Viral Disease Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Poultry Viral Disease Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Poultry Viral Disease Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Poultry Viral Disease Vaccines Sales by Country (K Units), 2021–2026
Table 32. Europe Poultry Viral Disease Vaccines Sales by Country (K Units), 2027–2032
Table 33. Europe Poultry Viral Disease Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Poultry Viral Disease Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Poultry Viral Disease Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Poultry Viral Disease Vaccines Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Poultry Viral Disease Vaccines Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Poultry Viral Disease Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Poultry Viral Disease Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Poultry Viral Disease Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Poultry Viral Disease Vaccines Sales by Country (K Units), 2021–2026
Table 42. Latin America Poultry Viral Disease Vaccines Sales by Country (K Units), 2027–2032
Table 43. Latin America Poultry Viral Disease Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Poultry Viral Disease Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Poultry Viral Disease Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Poultry Viral Disease Vaccines Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Poultry Viral Disease Vaccines Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Poultry Viral Disease Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Poultry Viral Disease Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Poultry Viral Disease Vaccines Sales (K Units) by Type (2021–2026)
Table 51. Global Poultry Viral Disease Vaccines Sales (K Units) by Type (2027–2032)
Table 52. Global Poultry Viral Disease Vaccines Sales Market Share by Type (2021–2026)
Table 53. Global Poultry Viral Disease Vaccines Sales Market Share by Type (2027–2032)
Table 54. Global Poultry Viral Disease Vaccines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Poultry Viral Disease Vaccines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Poultry Viral Disease Vaccines Revenue Market Share by Type (2021–2026)
Table 57. Global Poultry Viral Disease Vaccines Revenue Market Share by Type (2027–2032)
Table 58. Global Poultry Viral Disease Vaccines Price (US$/Unit) by Type (2021–2026)
Table 59. Global Poultry Viral Disease Vaccines Price (US$/Unit) by Type (2027–2032)
Table 60. Global Poultry Viral Disease Vaccines Sales (K Units) by Application (2021–2026)
Table 61. Global Poultry Viral Disease Vaccines Sales (K Units) by Application (2027–2032)
Table 62. Global Poultry Viral Disease Vaccines Sales Market Share by Application (2021–2026)
Table 63. Global Poultry Viral Disease Vaccines Sales Market Share by Application (2027–2032)
Table 64. Global Poultry Viral Disease Vaccines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Poultry Viral Disease Vaccines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Poultry Viral Disease Vaccines Revenue Market Share by Application (2021–2026)
Table 67. Global Poultry Viral Disease Vaccines Revenue Market Share by Application (2027–2032)
Table 68. Global Poultry Viral Disease Vaccines Price (US$/Unit) by Application (2021–2026)
Table 69. Global Poultry Viral Disease Vaccines Price (US$/Unit) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Merck Poultry Viral Disease Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Boehringer Ingelheim Poultry Viral Disease Vaccines Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Ceva Company Information
Table 81. Ceva Description and Business Overview
Table 82. Ceva Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Ceva Poultry Viral Disease Vaccines Product
Table 84. Ceva Recent Developments/Updates
Table 85. Zoetis Company Information
Table 86. Zoetis Description and Business Overview
Table 87. Zoetis Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Zoetis Poultry Viral Disease Vaccines Product
Table 89. Zoetis Recent Developments/Updates
Table 90. Vaxxinova® Company Information
Table 91. Vaxxinova® Description and Business Overview
Table 92. Vaxxinova® Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Vaxxinova® Poultry Viral Disease Vaccines Product
Table 94. Vaxxinova® Recent Developments/Updates
Table 95. Elanco Company Information
Table 96. Elanco Description and Business Overview
Table 97. Elanco Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Elanco Poultry Viral Disease Vaccines Product
Table 99. Elanco Recent Developments/Updates
Table 100. QYH Biotech Co., Ltd Company Information
Table 101. QYH Biotech Co., Ltd Description and Business Overview
Table 102. QYH Biotech Co., Ltd Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. QYH Biotech Co., Ltd Poultry Viral Disease Vaccines Product
Table 104. QYH Biotech Co., Ltd Recent Developments/Updates
Table 105. Pulike Company Information
Table 106. Pulike Description and Business Overview
Table 107. Pulike Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Pulike Poultry Viral Disease Vaccines Product
Table 109. Pulike Recent Developments/Updates
Table 110. Phibro Animal Health Corporation Company Information
Table 111. Phibro Animal Health Corporation Description and Business Overview
Table 112. Phibro Animal Health Corporation Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Phibro Animal Health Corporation Poultry Viral Disease Vaccines Product
Table 114. Phibro Animal Health Corporation Recent Developments/Updates
Table 115. JinYu Biotechnology Company Information
Table 116. JinYu Biotechnology Description and Business Overview
Table 117. JinYu Biotechnology Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. JinYu Biotechnology Poultry Viral Disease Vaccines Product
Table 119. JinYu Biotechnology Recent Developments/Updates
Table 120. Harbin Pharmaceutical Group Company Information
Table 121. Harbin Pharmaceutical Group Description and Business Overview
Table 122. Harbin Pharmaceutical Group Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Harbin Pharmaceutical Group Poultry Viral Disease Vaccines Product
Table 124. Harbin Pharmaceutical Group Recent Developments/Updates
Table 125. MEVAC Company Information
Table 126. MEVAC Description and Business Overview
Table 127. MEVAC Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. MEVAC Poultry Viral Disease Vaccines Product
Table 129. MEVAC Recent Developments/Updates
Table 130. Venky's Company Information
Table 131. Venky's Description and Business Overview
Table 132. Venky's Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Venky's Poultry Viral Disease Vaccines Product
Table 134. Venky's Recent Developments/Updates
Table 135. Japfa Comfeed Indonesia Company Information
Table 136. Japfa Comfeed Indonesia Description and Business Overview
Table 137. Japfa Comfeed Indonesia Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Japfa Comfeed Indonesia Poultry Viral Disease Vaccines Product
Table 139. Japfa Comfeed Indonesia Recent Developments/Updates
Table 140. Nisseiken Company Information
Table 141. Nisseiken Description and Business Overview
Table 142. Nisseiken Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Nisseiken Poultry Viral Disease Vaccines Product
Table 144. Nisseiken Recent Developments/Updates
Table 145. Hile Company Information
Table 146. Hile Description and Business Overview
Table 147. Hile Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Hile Poultry Viral Disease Vaccines Product
Table 149. Hile Recent Developments/Updates
Table 150. Hester Biosciences Company Information
Table 151. Hester Biosciences Description and Business Overview
Table 152. Hester Biosciences Poultry Viral Disease Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Hester Biosciences Poultry Viral Disease Vaccines Product
Table 154. Hester Biosciences Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Poultry Viral Disease Vaccines Distributors List
Table 158. Poultry Viral Disease Vaccines Customers List
Table 159. Poultry Viral Disease Vaccines Market Trends
Table 160. Poultry Viral Disease Vaccines Market Drivers
Table 161. Poultry Viral Disease Vaccines Market Challenges
Table 162. Poultry Viral Disease Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report


List of Figures
Figure 1. Product Picture of Poultry Viral Disease Vaccines
Figure 2. Global Poultry Viral Disease Vaccines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Poultry Viral Disease Vaccines Market Share by Type: 2025 & 2032
Figure 4. Live Product Picture
Figure 5. Attenuated Product Picture
Figure 6. Killed Product Picture
Figure 7. Global Poultry Viral Disease Vaccines Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Poultry Viral Disease Vaccines Market Share by Application: 2025 & 2032
Figure 9. NDV
Figure 10. Marek ' s Disease
Figure 11. IBD
Figure 12. Infectious Bronchitis
Figure 13. Influenza
Figure 14. Others
Figure 15. Global Poultry Viral Disease Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Poultry Viral Disease Vaccines Market Size (US$ Million), 2021–2032
Figure 17. Global Poultry Viral Disease Vaccines Sales (K Units), 2021–2032
Figure 18. Global Poultry Viral Disease Vaccines Average Price (US$/Unit), 2021–2032
Figure 19. Poultry Viral Disease Vaccines Report Years Considered
Figure 20. Poultry Viral Disease Vaccines Sales Share by Manufacturers in 2025
Figure 21. Global Poultry Viral Disease Vaccines Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Poultry Viral Disease Vaccines Players: Market Share by Revenue in Poultry Viral Disease Vaccines in 2025
Figure 23. Poultry Viral Disease Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Poultry Viral Disease Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Poultry Viral Disease Vaccines Sales Market Share by Country (2021–2032)
Figure 26. North America Poultry Viral Disease Vaccines Revenue Market Share by Country (2021–2032)
Figure 27. United States Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Poultry Viral Disease Vaccines Sales Market Share by Country (2021–2032)
Figure 30. Europe Poultry Viral Disease Vaccines Revenue Market Share by Country (2021–2032)
Figure 31. Germany Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Poultry Viral Disease Vaccines Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Poultry Viral Disease Vaccines Revenue Market Share by Region (2021–2032)
Figure 38. China Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Poultry Viral Disease Vaccines Sales Market Share by Country (2021–2032)
Figure 46. Latin America Poultry Viral Disease Vaccines Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Poultry Viral Disease Vaccines Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Poultry Viral Disease Vaccines Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Poultry Viral Disease Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Poultry Viral Disease Vaccines by Type (2021–2032)
Figure 57. Global Revenue Market Share of Poultry Viral Disease Vaccines by Type (2021–2032)
Figure 58. Global Poultry Viral Disease Vaccines Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Poultry Viral Disease Vaccines by Application (2021–2032)
Figure 60. Global Revenue Market Share of Poultry Viral Disease Vaccines by Application (2021–2032)
Figure 61. Global Poultry Viral Disease Vaccines Price (US$/Unit) by Application (2021–2032)
Figure 62. Poultry Viral Disease Vaccines Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies